Metabotropic glutamate receptor ligands are protective in experimental animal models of Parkinson's disease

被引：0
|
作者：
Battaglia, G
Fornai, F
Busceti, CL
Bovolin, P
Bruno, V
Nicoletti, F
机构：
[1] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, Rome, Italy
[2] Univ Turin, Dept Human & Anim Biol, Turin, Italy
[3] Univ Pisa, Dept Human Morphol & Appl Biol, Pisa, Italy
来源：
NEUROPHARMACOLOGY | 2002年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
11
引用
收藏
页码：275 / 276
页数：2
相关论文
共 50 条
  • [41] Glutamate receptor genes in Parkinson's disease
    Penney, JB
    Standaert, DG
    Testa, CM
    Landwehrmeyer, GB
    Young, AB
    PARKINSON'S DISEASE, 1996, 69 : 79 - 86
  • [42] The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease
    Johnson, Kari A.
    Jones, Carrie K.
    Tantawy, Mohammed N.
    Bubser, Michael
    Marvanova, Marketa
    Ansari, M. Sib
    Baldwin, Ronald M.
    Conn, P. Jeffrey
    Niswender, Colleen M.
    NEUROPHARMACOLOGY, 2013, 66 : 187 - 195
  • [43] Role of metabotropic glutamate receptors in neurodegeneration/neuroprotection mechanisms in experimental animal models of Parkinsonism
    Battaglia, G
    Busceti, LC
    Molinaro, G
    Biagioni, F
    Storto, M
    Fornai, F
    Bruno, V
    Nicoletti, F
    Corti, C
    NEUROPHARMACOLOGY, 2005, 49 : 232 - 233
  • [44] Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment
    Marino, MJ
    Williams, DL
    O'Brien, JA
    Valenti, O
    McDonald, TP
    Clements, MK
    Wang, RP
    DiLella, AG
    Hess, JF
    Kinney, GG
    Conn, PJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) : 13668 - 13673
  • [45] Group III and subtype 4 metabotropic glutamate receptor agonists: Discovery and pathophysiological applications in Parkinson's disease
    Amalric, M.
    Lopez, S.
    Goudet, C.
    Fisone, G.
    Battaglia, G.
    Nicoletti, F.
    Pin, J. -P.
    Acher, F. C.
    NEUROPHARMACOLOGY, 2013, 66 : 53 - 64
  • [46] Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment
    Cuomo, Dario
    Martella, Giuseppina
    Barabino, Emanuela
    Platania, Paola
    Vita, Daniela
    Madeo, Graziella
    Selvam, Chelliah
    Goudet, Cyril
    Oueslati, Nadia
    Pin, Jean-Philippe
    Acher, Francine
    Pisani, Antonio
    Beurrier, Corinne
    Melon, Christophe
    Kerkerian-Le Goff, Lydia
    Gubellini, Paolo
    JOURNAL OF NEUROCHEMISTRY, 2009, 109 (04) : 1096 - 1105
  • [47] Metabotropic glutamate receptors : Potential pharmacological targets in Parkinson's disease treatment
    Amalric, M
    Turle-Lorenzo, N
    Lopez, S
    NEUROPHARMACOLOGY, 2005, 49 : 231 - 231
  • [48] The anxiolytic-like effects of metabotropic glutamate receptor ligands
    Pilc, A
    Stachowicz, K
    Klak, K
    Chojnacka-Wojcik, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S321 - S322
  • [49] Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease
    Abd-Elrahman, Khaled S.
    Ferguson, Stephen S. G.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 235 - 254
  • [50] Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs
    Palucha, Agnieszka
    Pilc, Andrzej
    PHARMACOLOGY & THERAPEUTICS, 2007, 115 (01) : 116 - 147
12345